BRPI0620185B8 - formulação farmacêutica, comprimidos, e, processo para a preparação de uma formulação farmacêutica - Google Patents

formulação farmacêutica, comprimidos, e, processo para a preparação de uma formulação farmacêutica

Info

Publication number
BRPI0620185B8
BRPI0620185B8 BRPI0620185A BRPI0620185A BRPI0620185B8 BR PI0620185 B8 BRPI0620185 B8 BR PI0620185B8 BR PI0620185 A BRPI0620185 A BR PI0620185A BR PI0620185 A BRPI0620185 A BR PI0620185A BR PI0620185 B8 BRPI0620185 B8 BR PI0620185B8
Authority
BR
Brazil
Prior art keywords
pharmaceutical formulation
weight
tablets
preparing
water
Prior art date
Application number
BRPI0620185A
Other languages
English (en)
Inventor
Mittwollen Jan-Peter
Kolter Karl
Wichtner Marcus
Schönherr Michael
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of BRPI0620185A2 publication Critical patent/BRPI0620185A2/pt
Publication of BRPI0620185B1 publication Critical patent/BRPI0620185B1/pt
Publication of BRPI0620185B8 publication Critical patent/BRPI0620185B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)

Abstract

formulação farmacêutica, tabletes, e, processo para a preparação de uma formulação farmacêutica. a invenção refere-se a uma formulação farmacêutica na forma de aglomerados contendo a) 60 - 97% em peso de açúcar ou álcoois de açúcar, b) 1 - 25% em peso de polivinilpirrolidona reticulada, c) 1 - 15% em peso polímeros de formação de filme, insolúveis em água, d) 0 - 15% em peso polímeros solúveis em água, e e) 0 - 15% em peso de outros auxiliares farmacêuticamente adequados, a soma dos componentes a) até e) perfazendo 100% em peso.
BRPI0620185A 2005-12-21 2006-12-11 formulação farmacêutica, comprimidos, e, processo para a preparação de uma formulação farmacêutica BRPI0620185B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05112654.8 2005-12-21
EP05112654 2005-12-21
EP05112969.0 2005-12-23
EP05112969 2005-12-23
PCT/EP2006/069515 WO2007071581A2 (de) 2005-12-21 2006-12-11 Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten

Publications (3)

Publication Number Publication Date
BRPI0620185A2 BRPI0620185A2 (pt) 2013-01-15
BRPI0620185B1 BRPI0620185B1 (pt) 2020-04-14
BRPI0620185B8 true BRPI0620185B8 (pt) 2021-05-25

Family

ID=37943972

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0620185A BRPI0620185B8 (pt) 2005-12-21 2006-12-11 formulação farmacêutica, comprimidos, e, processo para a preparação de uma formulação farmacêutica

Country Status (9)

Country Link
US (1) US8425935B2 (pt)
EP (1) EP1965761B1 (pt)
JP (1) JP5209492B2 (pt)
KR (1) KR101358528B1 (pt)
AU (1) AU2006328585B2 (pt)
BR (1) BRPI0620185B8 (pt)
CA (1) CA2634357A1 (pt)
DE (1) DE202006020168U1 (pt)
WO (1) WO2007071581A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5420535B2 (ja) * 2007-06-06 2014-02-19 ビーエーエスエフ ソシエタス・ヨーロピア 速崩性錠剤製造のための医薬製剤
WO2008148734A1 (de) * 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von kau- und lutsch-tabletten
JP5627455B2 (ja) * 2007-06-06 2014-11-19 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 速崩性錠剤製造のための医薬製剤
US8568780B2 (en) 2007-06-06 2013-10-29 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
WO2009004440A2 (en) * 2007-06-29 2009-01-08 Orchid Chemicals & Pharmaceuticals Limited Quick dissolve compositions of memantine hydrochloride
US9386783B2 (en) * 2007-07-31 2016-07-12 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Confectionery products and process for obtaining them
EP2039255A1 (de) * 2007-09-14 2009-03-25 Basf Se Formulierungen von Nahrungsergänzungsmitteln und festen, sich im Mund auflösenden süßen Genußmitteln
EP2042160A1 (de) * 2007-09-14 2009-04-01 Basf Se Mittel für die Behandlung von Mund und Rachen in Form von Tabletten
DE102008012295A1 (de) * 2008-03-03 2009-09-17 Südzucker AG Mannheim/Ochsenfurt Gemisch zur Herstellung von schnell zerfallenden Tabletten
KR101704156B1 (ko) * 2008-11-25 2017-02-07 미쓰비시 타나베 파마 코퍼레이션 구강 내 속붕괴성정을 제조하기 위한 혼합물
WO2010077878A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
US20110027374A1 (en) * 2008-12-16 2011-02-03 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
US8617588B2 (en) 2009-03-09 2013-12-31 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
JP2012528819A (ja) * 2009-06-04 2012-11-15 ビーエーエスエフ ソシエタス・ヨーロピア 味マスク活性成分含有口腔内崩壊性投薬形態
WO2011051155A2 (en) 2009-10-28 2011-05-05 Basf Se Stable protective coatings for pharmaceutical dosage forms
CN103189052A (zh) 2010-09-07 2013-07-03 巴斯夫欧洲公司 基于含氨基聚合物的共聚物作为基质粘合剂在制备含活性成分的颗粒和给药形式中的用途
US9795576B2 (en) 2010-09-27 2017-10-24 Basf Se Protective coatings for acidic active ingredients
WO2012041788A1 (de) 2010-09-27 2012-04-05 Basf Se Protektive überzüge für saure wirkstoffe
CN103384517A (zh) * 2010-12-22 2013-11-06 巴斯夫欧洲公司 快速崩解的固体包衣剂型
US8715729B2 (en) 2010-12-22 2014-05-06 Basf Se Rapidly disintegrating, solid coated dosage form
EP2683365A1 (de) * 2011-03-09 2014-01-15 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
JP6718866B2 (ja) * 2014-10-16 2020-07-08 カーギル インコーポレイテッド 直接圧縮性のエリスリトールの調製方法及びその使用
EP3135272A1 (en) 2015-08-31 2017-03-01 Basf S.A. Compositions for mouth wash in the form of tablets

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087360A (en) * 1975-09-24 1978-05-02 Olin Corporation Method of inhibiting scale formation
US5569469A (en) * 1984-10-16 1996-10-29 Vectorpharma International, S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
DE19709663A1 (de) * 1997-03-10 1998-09-17 Basf Ag Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen
FR2781152B1 (fr) * 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
MY154010A (en) * 1998-07-28 2015-04-30 Takeda Pharmaceutical Rapidly disintegrable solid preparation
KR20010006835A (ko) * 1999-03-25 2001-01-26 김선진 경구용 속붕해정
US20020071864A1 (en) 1999-03-25 2002-06-13 Yuhan Corporation Rapidly disintegrable tablet for oral administration
US6495177B1 (en) * 1999-08-13 2002-12-17 Warner Chilcott Laboratories Ireland Limited Orally dissolvable nutritional supplement
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2002045694A1 (en) * 2000-12-07 2002-06-13 Altana Pharma Ag Rapidly disintegrating tablet comprising an acid-labile active ingredient
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
EP1455813B1 (en) 2001-12-18 2015-07-15 mondoBIOTECH AG Interferon gamma in combination with a diagnostic array for use in the improved treatment of idiopathic pulmonary fibrosis
GB0204771D0 (en) 2002-02-28 2002-04-17 Phoqus Ltd Fast disintegrating tablets
JP2004265216A (ja) 2003-03-03 2004-09-24 Seiko Epson Corp 印刷装置、受信装置、中継装置、印刷システムおよび印刷方法
JP4446177B2 (ja) * 2005-01-21 2010-04-07 東和薬品株式会社 耐湿性口腔内崩壊錠の製造方法
US7572390B2 (en) * 2005-06-22 2009-08-11 Truox, Inc. Composition and method for reducing chemical oxygen demand in water

Also Published As

Publication number Publication date
BRPI0620185A2 (pt) 2013-01-15
JP2009520744A (ja) 2009-05-28
KR20080080197A (ko) 2008-09-02
KR101358528B1 (ko) 2014-02-06
EP1965761B1 (de) 2015-07-01
EP1965761A2 (de) 2008-09-10
JP5209492B2 (ja) 2013-06-12
WO2007071581A3 (de) 2008-01-10
US8425935B2 (en) 2013-04-23
DE202006020168U1 (de) 2008-07-17
BRPI0620185B1 (pt) 2020-04-14
US20080299194A1 (en) 2008-12-04
AU2006328585B2 (en) 2012-05-03
CA2634357A1 (en) 2007-06-28
WO2007071581A2 (de) 2007-06-28
AU2006328585A1 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
BRPI0620185B8 (pt) formulação farmacêutica, comprimidos, e, processo para a preparação de uma formulação farmacêutica
BRPI0812064B8 (pt) formulação farmacêutica na forma de aglomerados, comprimidos, e, processo para a produção de uma formulação farmacêutica
BRPI0616694B8 (pt) processo para preparar comprimido farmacêutico com 80 e 96% em peso com base no peso seco de vildagliptina e metformina ou seus sais farmaceuticamente aceitáveis
BRPI0608853B8 (pt) composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes
WO2006076620A3 (en) Bendamustine pharmaceutical compositions for lyophilisation
WO2004074266A8 (en) Hiv inhibiting 1,2,4-triazines
MX2009002757A (es) Formulacion de farmaco resistente al abuso.
NO20091501L (no) Farmasoytiske sammensetninger
BRPI0513058A (pt) derivado de pirimidina ou um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um derivado de pirimidina ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, método para produzir um efeito anti-proliferativo em um animal de sangue quente
CL2004000303A1 (es) Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
HRP20150375T1 (hr) Derivati piridazinona
BRPI0513050A (pt) derivado de perimidina ou um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um derivado de pirimidina ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, método para produzir um efeito anti-proliferativo em um animal de sangue quente
WO2007064448A3 (en) Cancer treatment using fts and 2-deoxyglucose
BRPI0716495A2 (pt) (r,r)-fenoterol e análogos de (r,r)- ou (r,s)-fenoterol, uso dos mesmos na preparação de composição farmacêutica e composição farmacêutica compreendendo o referidos compostos.
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
PT103884A (pt) Composições de libertação prolongada e métodos para a sua preparação
SI2805723T1 (en) Cladribine regimen for the treatment of multiple sclerosis
ATE542525T1 (de) Verbesserte pharmazeutische zusammensetzung mit einem pyrrolidon-antikonvulsivum und verfahren zu seiner herstellung
WO2009109289A3 (de) Gemisch zur herstellung von schnell zerfallenden tabletten
ATE402706T1 (de) Im mund zerfallende pharmazeutische zusammensetzung mit risperidon
FR2883181B1 (fr) Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
BRPI0715609A2 (pt) Composto, uso de um composto, métodos para produzir um efeito antiproliferativo em um animal de sangue quente, e para tratar uma doença em um animal de sangue quente, e, composição farmacêutica
UA89656C2 (ru) Фармацевтическая композиция, которая диспергируется перорально, и способ ее приготовления
WO2006133194A3 (en) Methods for treating viral infection with oral or injectible drug solution
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/04/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/12/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B22B Petition not considered [chapter 22.2 patent gazette]

Free format text: NAO CONHECIDA A PETICAO NO 870210067130, DE 23/07/2021, EM VIRTUDE DO DISPOSTO NO ART. 219 , INCISO II DA LPI